University of Thessaly (UTH)
Μεταλλάξεις του γονιδίου της ενδογλίνης στην κληρονομική αιμορραγική τηλαγγειεκτασία
Abstract
dc:descriptionHereditary hemorrhagic telangiectasia (HHT) is an inherited autosomal dominant vascular dysplasia that occures at a frequency of 1 in 10000 and exhibits age-related penetrance with variable expression. The disorder is characterized by mucocutaneous telangiectases affecting the tongue, lips, fingers, ears and conjunctivae, in association with frequent epistaxis and gastrointestinal hemorrhages. Further clinical manifestations are pulmonary arteriovenous malformations, hepatic arteriovenous malformations and, in rare cases, splinal cord arteriovenous malformations, cerebral arteriovenous malformation, aneurysm and migraine headache.HHT is a genetically heterogeneous disorder. The first locus, HHT type 1, was mapped to chromosome 9q33-34, where Endoglin was defined as the affected gene. The second locus, HHT type 2, ALK-1 maps to chromosome 12q13. The third locus, HHT type 3, maps to chromosome 5 and the forth locus, HHT type 4, maps to chromosome 7.Endoglin is a homodimeric integral membrane glycoprotein who is expressed primarily in the vascular endothelial cell of capillaries, arterioles and venues.To date, 328 different mutations have been identified in the endoglin gene. These mutations include various deletions, splice site changes, small nucleotide insertions and deletions leading to frameshifts and premature stop codons. Mutations in the gene of Endoglin cause problems in the angiogenesis and in the reformation of conjunctive tissue.The aim of this study is to search for new or known mutations in Greek population, to determine if these mutations of endoglin are responsible for the Hereditary Hemorrhagic Telangiectasia type 1.PATIENTS AND METHODSWe studied 4 families with HHT originating from Thessalia, Greece and 6 families from Crete, Greece. In addition we studied 11 isolated patients originating from Crete. Genomic DNA was isolated from peripheral blood lymphomonocytes or lymphoblastoid B-cell lines using the method of phenol-chloroform-isoamyl alcohol. Polymerase chain reaction (PCR, Real-Time PCR, RT-PCR) using flanking primers corresponding to intronic sequences for the amplification of exon sequences were designed in our laboratory based on the sequences of genes ENG recorded in GenBank (ENG - OMIM: 232295; 187300; GenBank: AH006911.1, BC014271.2). In most of the exons nested PCR was used, for further enhancement and discrimination of the product. Direct sequencing was used for analysis of nucleotide sequence of the DNA using the enzymatic method described by Sanger(Larc laboratories, Endimburg).RESULTSIn this group of patients, two novel, two previously reported mutations, and two polymorphisms were detected. The novel mutations included a large deletion of exon 2, 3 and και 4 (family 3,4,5,6 from Crete, patients 0.5, 0.6, 0.7, 0.8 from Crete) and a duplication from the point 68 to 523 in exon 2 (patient 0.9 from Crete).The previously reported mutations included a deletion of a C in exon 1 (family 1 and 2 from Crete, patients 0.1, 0.2, 0.3 και 0.4 from Crete) and a deletion at the point 332-338 in exon 3 (patient 010 from Crete). The two polymorphisms included an insertion of a C at the point 35 of exon 1 (family 7 from Thessaly) and an insertion of a G at the point 315 in intron 11-12 (family 10 from Thessaly).CONCLUSIONIn our study we found mutations (new and already known), located in exons 1 to 11, which encode the extracellular portion of the protein. These mutations are leading to premature stop codons and abortive polypeptides. The mutant proteins are rarely detected and even when they are expressed, they do not appear at the cell membrane. Mutations that lead to a change in Frameshift are, possibly, reducing the levels of mRNA and leading to very unstable mutant proteins.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Theodosiou, Vasiliki
- Θεοδοσίου, Βασιλική
Subjects
dc:subject × 18- Μεταλλάξεις ενδογλίνης
- Κληρονομική αιμορραγική τηλαγγειεκτασία
- HHT
- Hereditary hemorragic telangiectasia
- Osler-rendu-weber
- Endoglin mutation
- Βιολογία
- Φυσικές Επιστήμες
- Βιοχημεία και Μοριακή βιολογία
- Βιοχημικές ερευνητικές μέθοδοι
- Ιατρική Βιοτεχνολογία
- Ιατρική και Επιστήμες Υγείας
- Biological Sciences
- Natural Sciences
- Biochemistry and Molecular Biology
- Biochemical Research Methods
- Medical Biotechnology
- Medical and Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29441